← SynDRA
GSK189254
SynDRA canonical compound SYN0011888 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HRH3 |
|---|
| Mechanism of action | histamine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- HRH3 ANTAGONIST
- Histamine H3 receptor antagonist
- HRH3 INVERSE AGONIST
- histamine receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- GSK-189254
- GSK189254A
- GSK-189254A
- UNII-5T4TX6CO53
- CHEMBL517140
- 5T4TX6CO53
- 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide
- 6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide
- WROHEWWOCPRMIA-UHFFFAOYSA-N
- SCHEMBL169579
- ZINC3961799
- AOB87474
- EX-A1905
- ABP000814
- BDBM50247054
- AKOS032944981
- CS-6206
- BCP9000737
- GSK-189,254
- KB-77605
- HY-14111
- Gsk-189254
- GSK-189254 free base
- RefChem:922531
- MFCD16987635
- orb1296230
- SCHEMBL29769888
- GTPL10736
- GLXC-90303
- HMS3748C15
- GSK189254A?
- VDB69073
- EBC-07631
- AC-36239
- DA-73901
- MS-25443
- SY389281
- EN300-36038
Look up GSK189254 in the interactive SynDRA portal →